HDAC9 and acute myeloid leukemia: For instance, the SMAC mimetic compound BV6 synergizes with DAC, cytarabine, or HDAC inhibitors in acute myeloid leukemia (AML) (Steinhart et al., 2013; Chromik et al., 2014; Steinwascher et al., 2015).